CG Oncology, Inc.
Developing an oncolytic immunotherapy program for non-muscle invasive bladder cancer across multiple disease settings.
Oncology / bladder cancer · Oncolytic immunotherapy · Late clinical (Phase 3)
Developing an oncolytic immunotherapy program for non-muscle invasive bladder cancer across multiple disease settings.
Oncology / bladder cancer · Oncolytic immunotherapy · Late clinical (Phase 3)